We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Genedata and Roche Join Forces in Proteomics Process

Genedata and Roche Join Forces in Proteomics Process

Genedata and Roche Join Forces in Proteomics Process

Genedata and Roche Join Forces in Proteomics Process

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Genedata and Roche Join Forces in Proteomics Process"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Genedata has announced an agreement with Roche for the company’s Genedata Expressionist ® Refiner MS module.

As integral part of the Genedata Expressionist platform for biomarker discovery, Refiner MS performs automated quality assessment and pre-processing of mass spectrometry based proteomics and metabolomics data.

The module handles all MS data formats in a flexible high throughput process, providing real-time interactive data quality assessment and processing hundreds of chromatograms simultaneously.

This high flexibility/high throughput duality accounts for the value Refiner MS adds to Roche`s biomarker discovery and diagnostic strategy.

Dr. Hanno Langen, Section Head Proteomics-Pathways-Functional Genomics in the Roche Molecular Medicine Laboratories in Basel, explains, “Thanks to its open architecture, Refiner MS can be easily positioned in our lab workflows, allowing for optimal integration. The high performance qualities make it a key element in our proteomics process, for which the processing of large datasets is fundamental.”

“We are proud to support Roche in further developing their biomarker discovery operations,” says Dr. Othmar Pfannes, CEO of Genedata AG. “The successful positioning of Refiner MS in such a complex, multifaceted environment validates its excellent suitability for modern proteomics applications.”